D. Quarteronet

Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor

M. Burgevin, E. Habert-Ortoli, I. Loquet, 2007, Journal of Molecular Neuroscience.

Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

G. Fur, A. Uzan, C. Malgouris, 1983, Journal of neurochemistry.

Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transport

M. Castel, P. Laduron, M. Burgevin, 1992, Neuroscience.

Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones.

J. Sulon, F. Lévi, Y. Touitou, 1987, Chronobiology international.

Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors

G. Fur, A. Uzan, C. Malgouris, 1984, Neuropharmacology.

Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2.

M. Dreyer, T. Rooney, D. Lesuisse, 2010, Bioorganic & medicinal chemistry letters.

Localization of presenilin-1 mRNA in rat brain.

F. Petitet, C. Czech, L. Pradier, 1996, Neuroreport.

Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients.

G. Le Fur, A. Uzan, P. Plouin, 1984, Biochemical pharmacology.